How to Meet Compliance and Records Requirements of the US Food and Drug Administration
This article was originally published in SRA
Records prove compliance. So why did 271 pharmaceutical or medical technology companies in the past 14 months receive regulatory enforcement notices from the US Food and Drug Administration citing records-related failures such as “failure to maintain accurate, complete, and current records”1 or “failure to retain all required records”2? Did the executives in these companies confuse standard operating procedures with FDA compliance?
You may also be interested in...
In its “robust, holistic hub” online, firms in the VMS product supply chain can determine their needs, “by product, solution or delivery formats,” and use a “comprehensive and unique portfolio” to “turn natural sources into shelf-ready products.”
Plus deals involving Astellas/Actinium, Sosei/PharmEnable, Aadi/EOC Pharma, BeiGene/Strand, Chi-Med/Inmagene, Alteogen/Intas, Sosei/AbbVie, Y-Biologics/3D Medicines.
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.